These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
857 related articles for article (PubMed ID: 33866000)
1. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Kadali RAK; Janagama R; Peruru S; Malayala SV Int J Infect Dis; 2021 May; 106():376-381. PubMed ID: 33866000 [TBL] [Abstract][Full Text] [Related]
2. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. Kadali RAK; Janagama R; Peruru S; Gajula V; Madathala RR; Chennaiahgari N; Malayala SV J Med Virol; 2021 Jul; 93(7):4420-4429. PubMed ID: 33822361 [TBL] [Abstract][Full Text] [Related]
3. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea. Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579 [TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study. Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030 [TBL] [Abstract][Full Text] [Related]
5. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community. Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613 [TBL] [Abstract][Full Text] [Related]
6. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea. Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
8. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience. Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085 [TBL] [Abstract][Full Text] [Related]
9. Side effects of messenger RNA vaccines and prior history of COVID-19, a cross-sectional study. Kadali RAK; Janagama R; Yedlapati SH; Kanike N; Gajula V; Madathala RR; Poddar S; Sukka N; Jogu HR; Racherla S; Shah I Am J Infect Control; 2022 Jan; 50(1):8-14. PubMed ID: 34718069 [TBL] [Abstract][Full Text] [Related]
10. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia. Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228 [No Abstract] [Full Text] [Related]
11. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan. Saita M; Yan Y; Ito K; Sasano H; Seyama K; Naito T J Infect Chemother; 2022 Jan; 28(1):116-119. PubMed ID: 34580011 [TBL] [Abstract][Full Text] [Related]
12. Safety and side effect profile of Pfizer-BioNTech COVID-19 vaccination among healthcare workers: A tertiary hospital experience in Singapore. Lim SM; Chan HC; Santosa A; Quek SC; Liu EHC; Somani J Ann Acad Med Singap; 2021 Sep; 50(9):703-711. PubMed ID: 34625758 [TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy. Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980 [TBL] [Abstract][Full Text] [Related]
14. Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers. Lee DY; Kang DY; Kim E; Lee SJ; Baek JH; Lee JS; Park MY; Im JH Medicine (Baltimore); 2023 Mar; 102(11):e33236. PubMed ID: 36930126 [TBL] [Abstract][Full Text] [Related]
15. Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine. Borroni E; Consonni D; Cugno M; Lombardi A; Mangioni D; Bono P; Oggioni M; Uceda Renteria S; Bordini L; Nava CD; Letzgus M; Gentiloni Silverj F; Castaldi S; Rognoni M; Cavallieri D'Oro L; Carugno M; Riboldi L; Ceriotti F; Bandera A; Gori A; Pesatori AC Med Lav; 2021 Dec; 112(6):477-485. PubMed ID: 34939617 [TBL] [Abstract][Full Text] [Related]
16. Emergency Department Utilization by In-hospital Healthcare Workers after COVID-19 Vaccination. Park MJ; Choi YJ; Choi S J Korean Med Sci; 2021 Jul; 36(27):e196. PubMed ID: 34254475 [TBL] [Abstract][Full Text] [Related]
17. Adverse events following BNT162b2 mRNA COVID-19 vaccination among healthcare workers: A single-centre experience in Malaysia. Gan LL; Zahidah AR; Hazirah T; Nabilah HK; Aisyah Z; Amin INM; Ng DCE Med J Malaysia; 2022 May; 77(3):300-305. PubMed ID: 35638485 [TBL] [Abstract][Full Text] [Related]
18. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia. Hassan YAM; Daud Ali M; Al-Eid RR; Al-Ghuraya FA; Essa Alqasimi Z; Ahmad A; Eltrafi Z; Ghosn SA Vaccine; 2022 Nov; 40(49):7087-7096. PubMed ID: 36404426 [TBL] [Abstract][Full Text] [Related]